Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation

Chavez et al.

  • Papers
  • Theranostics
  • June 2018

Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth

Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy

Zhang et al.

  • Papers
  • Science Advances
  • May 2017

High-content molecular profiling of T-cell therapy in oncology

Novosiadly et al.

  • Molecular Therapy — Oncolytics
  • Papers
  • February 2016

Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy

Liu et al.

  • Nature Biotechnology
  • Papers
  • February 2016

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

Lindsey M. Draper

  • Clinical Cancer Research
  • Papers
  • December 2015